Should you buy Aurinia Pharmaceuticals (AUPH)?
Updated
Aurinia Pharmaceuticals offers a rare combination of a four-quarter earnings beat streak, elite operating margins, and a below-market forward multiple, but the stock has nearly closed the gap to its near-term resistance target and free cash flow converts at less than half of reported net income — arguing for patience over immediate deployment.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
| Pillar | Expectation | Trend |
|---|---|---|
Gross margins of 100%, a Rule-of-40 score of 66, and a Piotroski F-Score of 8 out of 9 place this among the highest-quality franchises in its peer group, underpinned by a wide economic moat. Quality breakdown | Gross and operating margins remain above 90% and the Rule-of-40 score stays above 55 over the next four reported quarters. | →Stable |
| CounterFree cash flow converts at only 42% of reported net income — a flagged quality concern — meaning the headline profitability metrics overstate actual cash generation, and further deterioration in cash conversion could discount the apparent franchise quality. | ||
The company has beaten consensus estimates in each of the last four reported quarters, averaging a 171% positive surprise across the period, demonstrating a sustained pattern of under-promising and over-delivering. Catalyst breakdown | The beat streak extends through the next two quarterly reports, with each EPS surprise remaining above 0%. | →Stable |
| CounterThe average is heavily distorted by a single 606% beat in the February quarter; excluding that anomaly, the remaining surprises are far more modest, and mean-reversion in the next print could break the streak without any fundamental deterioration. | ||
A forward price-to-earnings multiple of 14.3 times and a PEG ratio of 0.25 make the stock attractively priced relative to both its own growth trajectory and industry peers, with 24% year-over-year earnings growth supporting the discount. Valuation breakdown | Forward P/E stays below 22 times and the PEG remains below 0.5 as earnings estimates hold or improve over the next 12 months. | →Stable |
| CounterThe price-to-earnings multiple is described as having expanded roughly 1.9 times as earnings normalize; if growth decelerates from recent elevated levels, the apparent discount could compress quickly, leaving today's valuation less attractive than it appears. | ||
Gross margins of 100%, a Rule-of-40 score of 66, and a Piotroski F-Score of 8 out of 9 place this among the highest-quality franchises in its peer group, underpinned by a wide economic moat.
→Stable- Expectation
- Gross and operating margins remain above 90% and the Rule-of-40 score stays above 55 over the next four reported quarters.
CounterFree cash flow converts at only 42% of reported net income — a flagged quality concern — meaning the headline profitability metrics overstate actual cash generation, and further deterioration in cash conversion could discount the apparent franchise quality.
The company has beaten consensus estimates in each of the last four reported quarters, averaging a 171% positive surprise across the period, demonstrating a sustained pattern of under-promising and over-delivering.
→Stable- Expectation
- The beat streak extends through the next two quarterly reports, with each EPS surprise remaining above 0%.
CounterThe average is heavily distorted by a single 606% beat in the February quarter; excluding that anomaly, the remaining surprises are far more modest, and mean-reversion in the next print could break the streak without any fundamental deterioration.
A forward price-to-earnings multiple of 14.3 times and a PEG ratio of 0.25 make the stock attractively priced relative to both its own growth trajectory and industry peers, with 24% year-over-year earnings growth supporting the discount.
→Stable- Expectation
- Forward P/E stays below 22 times and the PEG remains below 0.5 as earnings estimates hold or improve over the next 12 months.
CounterThe price-to-earnings multiple is described as having expanded roughly 1.9 times as earnings normalize; if growth decelerates from recent elevated levels, the apparent discount could compress quickly, leaving today's valuation less attractive than it appears.
▸ Show 2 more pillars▾ Show fewer
Despite strong reported net income, free cash flow represents only 42% of earnings — a red-flag quality concern indicating that reported profits are not fully materializing as cash on hand.
→Stable- Expectation
- Free cash flow as a percentage of net income rises above 65% over the next two to three quarters, signaling the earnings quality concern is resolving.
CounterIf the gap between reported earnings and cash generation reflects temporary working-capital timing rather than structural accrual inflation, it may self-correct without any negative impact on the income statement, making this concern transient.
With only 2.3% headroom remaining to the near-term resistance target of $16.37, the reward-to-risk ratio of 1.49 falls just short of the bar needed for favorable asymmetry — the setup favors patience over immediate entry.
→Stable- Expectation
- The stock pulls back to the $15.25 support zone before the July earnings date, restoring a more favorable entry geometry.
CounterThe technical setup is constructive — a golden cross, price above all major moving averages, RSI at 64, and a bullish MACD — and a strong July earnings print could push the price through current resistance, making today's near-target price the floor of a new range rather than the ceiling.
→ Full pillar scorecard with all 5 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1The company has beaten consensus estimates in each of the last four reported quarters, averaging a 171% positive surprise across the period, demonstrating a sustained pattern of under-promising and over-delivering.
Trip ifEPS surprise falls below 0% in any single reported quarter.
- P2Gross margins of 100%, a Rule-of-40 score of 66, and a Piotroski F-Score of 8 out of 9 place this among the highest-quality franchises in its peer group, underpinned by a wide economic moat.
Trip ifRule-of-40 score falls below 50 for 2 consecutive quarters.
- P3A forward price-to-earnings multiple of 14.3 times and a PEG ratio of 0.25 make the stock attractively priced relative to both its own growth trajectory and industry peers, with 24% year-over-year earnings growth supporting the discount.
Trip ifForward price-to-earnings multiple expands above 22 times for 2 consecutive quarters.
- P4Despite strong reported net income, free cash flow represents only 42% of earnings — a red-flag quality concern indicating that reported profits are not fully materializing as cash on hand.
Trip ifFree cash flow as a percentage of net income rises above 65% for 2 consecutive quarters.
- P5With only 2.3% headroom remaining to the near-term resistance target of $16.37, the reward-to-risk ratio of 1.49 falls just short of the bar needed for favorable asymmetry — the setup favors patience over immediate entry.
Trip ifPrice closes above $16.37 on volume more than 1.5 times the 20-day average, confirming a breakout through resistance.
How the engine reached this verdict
TrendMatrix's engine output for Aurinia Pharmaceuticals Inc (AUPH) is HOLD_IF_HOLDING with medium conviction, score 7.2/10 at $19.14. Bull and bear cases are roughly balanced; the engine output is HOLD because neither side cleared a positive-conviction threshold.
On the bull side: Strong earnings beat streak (4/4); Strong overall score: 7.2/10; High-quality business. On the bear side: Cyclical risk: PE expanding 1.9x (earnings normalizing); Analyst target reached - limited upside remaining; Near 52-week high (-1.2% away). Active engine warnings: V8: Target reached (-20.6% upside), V9 Gate Failed: ASYMMETRY:-1.4=NEGATIVE, V9 Gate Failed: INSIDER:0.54%=HEAVY.
The engine is not issuing fresh-money entry targets at the current verdict. The technical entry zone is around $15.91 with a technical stop near $14.80 for existing positions. Asymmetric R:R is 2.64, below the threshold (≥2.0) at which the engine would actively flag fresh capital. The engine's sizing output: 0.7% of portfolio at this asymmetry level (high-conviction tier).
HOLD flips toward BUY_WAIT if reward-to-risk (NEGATIVE) clears AND a co-confirming gate triggers. HOLD flips toward SELL if any of the currently-passing gates drop below threshold OR three or more dimensions fall below 4 simultaneously.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates AUPH — 10-dimension breakdown →
Bull case
- ▸Strong earnings beat streak (4/4)
- ▸Strong overall score: 7.2/10
- ▸High-quality business
Bear case
- ▸Cyclical risk: PE expanding 1.9x (earnings normalizing)
- ▸Analyst target reached - limited upside remaining
- ▸Near 52-week high (-1.2% away)